Elvin Lee and Jerald Hammann Call for Board Overhaul at Salarius Pharmaceuticals (SLRX) Amid Mismanagement Concerns
Key Summary: Elvin Lee and Jerald Hammann criticized Salarius Pharma's board for mismanagement and called for overhaul.Market Cap: $2 million | Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing treatments for cancers with unmet medical need.
Background
On October 27, 2023, Elvin Sanghwan Lee, an Individual In…